Charles Schwab’s Inhibrx, Inc. Common Stock INBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $8.09M | Buy |
|
|||||
|
2023
Q4 | $8.73M | Buy |
|
|||||
|
2023
Q3 | $3.89M | Sell |
|
|||||
|
2023
Q2 | $6.39M | Buy |
|
|||||
|
2023
Q1 | $4.56M | Sell |
|
|||||
|
2022
Q4 | $6.11M | Buy |
|
|||||
|
2022
Q3 | $3.98M | Buy |
|
|||||
|
2022
Q2 | $1.91M | Buy |
|
|||||
|
2022
Q1 | $3.67M | Buy |
|
|||||
|
2021
Q4 | $7.03M | Buy |
|
|||||
|
2021
Q3 | $5.27M | Buy |
|
|||||
|
2021
Q2 | $2.49M | Buy |
|
|||||
|
2021
Q1 | $1.03M | Buy |
|
|||||
|
2020
Q4 | $1.62M | Buy |
|